Oleic acid-based vesicular nanocarriers for topical delivery of the natural drug thymoquinone: Improvement of anti-inflammatory activity

被引:14
|
作者
Bruno, Maria Chiara [1 ]
Gagliardi, Agnese [1 ]
Mancuso, Antonia [2 ]
Barone, Antonella [2 ]
Tarsitano, Martine [1 ]
Cosco, Donato [1 ]
Cristiano, Maria Chiara [2 ]
Fresta, Massimo [1 ]
Paolino, Donatella [2 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Campus Univ S Venuta Bldg Biosci,Viale Europa, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Campus Univ S Venuta Bldg Biosci,Viale Europa, I-88100 Catanzaro, Italy
关键词
Oleic acid; Thymoquinone; Topical skin drug delivery; In vitro percutaneous permeation; In vivo evaluation; Human volunteers; IN-VIVO; SKIN; PERMEATION; ETHOSOMES; LIPOSOMES; STABILITY; KINETICS; PH;
D O I
10.1016/j.jconrel.2022.10.011
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The topical administration of a drug compound remains the first choice for the treatment of many local skin ailments. Many skin diseases can be treated by applying the active formulation directly to the skin, but unfortunately some drugs are unable to overcome the stratum corneum and exert their pharmacological action. An example is thymoquinone, a naturally derived drug obtained from Nigella sativa L. and potentially effective in the treatment of inflammatory and oxidative skin conditions. Since its physico-chemical properties are not suitable for overcoming the stratum corneum, we wanted to circumvent the problem by proposing new lipid-based nanovesicles called "oleoethosomes", made up of naturally derived ingredients, for its delivery. Among several formulations of oleoethosomes, the sample made up of 2% (w/w) oleic acid:PL90G 1:1 (molar ratio), and ethanol 15% showed the best physico-chemical characteristics and above all it showed the capacity to contain a suitable amount of thymoquinone (2 mg/ml). The formulation was tested in vitro on stratum corneum and viable epidermis membranes confirming its ability to induce the passage of thymoquinone through the human stratum corneum and to act as a permeation enhancer. In fact, it showed thymoquinone permeation values of 22.63 +/- 1.49% regarding the applied drug amount. Oleoethosomes were compared with oleosomes, another kind of naturally derived nanosystems but free of ethanol. The experimental data confirmed that ethanol was an important component that enhanced the activity of the oleoethosomes when tested on the skin of healthy volunteers. The thymoquinone-loaded oleoethosome treatment demonstrated a significantly greater extent of antiinflammatory activity than the treatment with thymoquinone-loaded oleosomes or the conventional dosage form of the drug. These in vivo results confirmed the synergic effect between oleic acid and ethanol on the lipid and protein compartments of the outermost skin layer, thus promoting a greater penetration capacity.
引用
收藏
页码:74 / 86
页数:13
相关论文
共 50 条
  • [31] Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery
    Barone, Antonella
    Cristiano, Maria Chiara
    Cilurzo, Felisa
    Locatelli, Marcello
    Iannotta, Dalila
    Di Marzio, Luisa
    Celia, Christian
    Paolino, Donatella
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 193
  • [32] Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties
    Pivetta, Thais P.
    Simoes, Sandra
    Araujo, Margarete M.
    Carvalho, Tania
    Arruda, Caroline
    Marcato, Priscyla D.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 164 : 281 - 290
  • [33] Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances
    Ferreira, Kezia Cristine Barbosa
    Valle, Ana Beatriz Caribe dos Santos
    Paes, Camila Quinetti
    Tavares, Guilherme Diniz
    Pittella, Frederico
    PHARMACEUTICS, 2021, 13 (09)
  • [34] Formulation of Glycyrrhizic Acid-based Nanocomplexes for Enhanced Anti-cancer and Anti-inflammatory Effects of Curcumin
    Song, Jihyeon
    Kim, Jun Yeong
    You, Gayeon
    Kang, Yoon Young
    Yang, Jiwon
    Mok, Hyejung
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2022, 27 (02) : 163 - 170
  • [35] Design and Characterization of Lipid-Surfactant-Based Systems for Enhancing Topical Anti-Inflammatory Activity of Ursolic Acid
    Fonseca-Santos, Bruno
    Araujo, Giovanna Angeli
    Ferreira, Paula Scanavez
    Victorelli, Francesca Damiani
    Pironi, Andressa Maria
    Araujo, Victor Hugo Sousa
    Carvalho, Suzana Goncalves
    Chorilli, Marlus
    PHARMACEUTICS, 2023, 15 (02)
  • [36] Molecular Docking and ADME Studies of Natural Compounds of Agarwood Oil for Topical Anti-Inflammatory Activity
    Yadav, Dharmendra K.
    Mudgal, Vipin
    Agrawal, Jyoti
    Maurya, Anil K.
    Bawankule, Dnyaneshwar U.
    Chanotiya, Chandan S.
    Khan, Feroz
    Thul, Sanjog T.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2013, 9 (03) : 360 - 370
  • [37] Formulation of Glycyrrhizic Acid-based Nanocomplexes for Enhanced Anti-cancer and Anti-inflammatory Effects of Curcumin
    Jihyeon Song
    Jun Yeong Kim
    Gayeon You
    Yoon Young Kang
    Jiwon Yang
    Hyejung Mok
    Biotechnology and Bioprocess Engineering, 2022, 27 : 163 - 170
  • [38] Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
    Wang, Huailan
    Zhou, Yunxiang
    Sun, Qunan
    Zhou, Chenghao
    Hu, Shiyao
    Lenahan, Cameron
    Xu, Weilin
    Deng, Yongchuan
    Li, Gonghui
    Tao, Sifeng
    Frontiers in Bioengineering and Biotechnology, 2021, 9
  • [39] Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
    Wang, Huailan
    Zhou, Yunxiang
    Sun, Qunan
    Zhou, Chenghao
    Hu, Shiyao
    Lenahan, Cameron
    Xu, Weilin
    Deng, Yongchuan
    Li, Gonghui
    Tao, Sifeng
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [40] Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool
    Thakur, Kanika
    Sharma, Gajanand
    Singh, Bhupindar
    Katare, Om Prakash
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (43) : 5108 - 5128